Leptin mimics many of the antidiabetic actions of insulin in insulin-deficient diabetes, but the mechanism is controversial. Fujikawa et al. (2013) reveal that leptin receptors in g-aminobutyric acid (GABA)-ergic and pro-opiomelanocortin (POMC) neurons in the central nervous system are sufficient to mediate the lifesaving and antidiabetic actions of leptin in insulin-deficient mice.
All physiological functions decline with age, but which changes are primary and which are secondary is not always clear. Liu et al. (2013) , examining functional changes in the muscles and motor neurons of C. elegans, suggest that when it comes to locomotion, it is the nervous system that shows earlier age-related deterioration.
An evident feature of human aging is the coexistence of multiple forms of agerelated functional deterioration, which individually and collectively become apparent in the later stages of the lifespan. Indeed, when we say sometimes that a person has died of old age, we mean that if it had not been this particular cause today, it might easily have been something else tomorrow. For example, a recent study of a representative cohort of 85 year olds found that three-quarters of them exhibited four or more different age-related conditions (Collerton et al., 2009) . The relationship between intrinsic aging and the multiplicity of diseases and disorders that show marked increases in prevalence with age lies at the heart of the biomedical efforts to understand how aging science might be applied to enhance the quality of later life. To make such a goal attainable, the field needs to uncover the complexity of age-related functional decline. This will involve discovering: (i) what explains the similarities (and differences) in the timing of failure of the different organ systems within the body; (ii) which of the underlying molecular mechanisms of cellular aging contribute most to the functional declines; and (iii) to what extent the driving mechanisms may differ from one organ system to another. Herein lies the challenge of a systems understanding of the biology of aging (Kirkwood 2008) . For a long time, something of a gulf existed between human and mammalian model systems, where organ-based pathobiology is well advanced, and research using invertebrate models (notably fruit flies and nematode worms), where genetic studies of longevity were highly amenable but detailed pathology was absent. In effect, answers were lacking to the following question: what does the aged worm or fly die from? Over the last decade, studies of age-related pathological changes in invertebrates have begun to bridge this gap (Herndon et al., 2002 , Huang et al., 2004 , Hsu et al., 2009 , Fontana et al., 2010 , Nishimura et al., 2011 , and a significant further step is taken by the report in this issue of Cell Metabolism from Liu et al. (2013), who have probed the intricacies of functional aging in Caenorhabditis elegans. They show that motor neurons exhibit a progressive functional decline beginning early in life, whereas muscles show no detectable functional deficit until mid to late life.
The most obvious manifestation of senescence in the aging worm is that it moves ever more slowly and eventually stops moving altogether. But movement is a complex phenotype requiring not only the action of the muscles, but also their activation by motor neurons. So, does locomotory senescence derive primarily from deterioration in muscles or in the nervous system? Previous work suggested that body wall muscles underwent primary functional aging, while the nervous system appeared to be relatively spared (Herndon et al., 2002) . However, these and other observations relied largely on analyzing morphology, which does not necessarily reveal the underlying functionality of the tissues. Liu et al. (2013) now perform a functional analysis of the aging nervous system and muscles in C. elegans across the lifespan using patch-clamp recordings. They confirm that the aged worm does indeed turn more slowly, the decline in speed beginning around day 5 and dropping steeply thereafter. This early slowing precedes the earliest signs of morphological deterioration in muscles, which do not appear until midlife (around day 10). Using electrophysiological recordings, they measured the frequency of spontaneous neurotransmitter release from presynaptic motor neurons, which reflects the activity of the motor nervous system in the body of the worm. The earliness of the observed decline led the authors to infer that it is aging in the nervous system that largely drives the decay in locomotory activity. Furthermore, in contrast to the early decline in the frequency of spontaneous neurotransmitter release, no alteration in the amplitude of the postsynaptic currents associated with such release occurs until midlife. The authors interpret this result as evidence for a lack of significant decline in the function of body wall muscle receptors. However, this observation does not alone preclude the possibility that muscle cells might nevertheless be deficient in initiating contraction in response to activation of muscle receptors. To exclude this possibility, the authors used the agonist levamisole, which acts upon the excitatory nicotinic acetylcholine receptors, to induce contraction. Using a real-time, automated tracking system, they found no deficit in contraction (rate or extent) before day 9, although some deterioration did appear by day 15.
Can we therefore conclude that, as far as worm locomotion is concerned, it is the nervous system that ages first, with the muscles deteriorating later? Although the results are an important advance, such a conclusion is premature. The question of primary causality will need further analysis. Liu et al. (2013) have progressed beyond morphological analysis to functional measurement, but we also need to understand the molecular events that underlie these functional changes before we can truly discern what is primary and what is secondary. The ultimate driving force of age-related deterioration is the accumulation of defects in the macromolecules and organelles that make up the relevant cells. Which types of faults contribute most to functional declines of the cells (and thereafter the tissues) and how the kinetics of such declines plays out across the life course are chapters yet to be written.
